Parental Experiences of Having a Child Diagnosed With Septo-Optic Dysplasia

IF 1.4 4区 医学 Q2 PEDIATRICS
David J. Cullingford, A. Marie Blackmore, Mary B. Abraham, Aris Siafarikas, Jenny Downs, Catherine S. Y. Choong
{"title":"Parental Experiences of Having a Child Diagnosed With Septo-Optic Dysplasia","authors":"David J. Cullingford,&nbsp;A. Marie Blackmore,&nbsp;Mary B. Abraham,&nbsp;Aris Siafarikas,&nbsp;Jenny Downs,&nbsp;Catherine S. Y. Choong","doi":"10.1111/jpc.70091","DOIUrl":null,"url":null,"abstract":"<p>Septo-optic dysplasia (SOD) is a congenital disorder affecting 1 in 10,000 births, defined by the presence of at least two of a clinical triad, consisting of optic nerve hypoplasia (ONH), midline brain defects and pituitary hormone deficiency [<span>1</span>]. Children with SOD may have vision impairment, hormonal deficiencies, developmental disorders, or epilepsy, but the clinical picture is highly variable [<span>2</span>]. The complexity of SOD, its interplay with family factors, and the need for multiple specialty commitments can make the diagnosis period a challenging time for families.</p><p>Parents of children with ONH (some who had SOD) have reported concerns at diagnosis, such as being given only the name of the condition and needing to seek further information by themselves, and that information being difficult to obtain [<span>3</span>]. These findings mirror concerns raised by families in our clinic population, which led to this study.</p><p>The aim of the present study was to investigate parent perceptions of their experiences during their child's SOD diagnosis, with particular focus on the adequacy of information provided.</p><p>Data about diagnostic experiences were collected from parents and carers of children with SOD using a survey administered in REDCap, as part of a larger cross-sectional observational study. Parents/carers were asked to indicate their level of agreement to six statements about the diagnostic process and respond to open-ended questions. A consumer reference group of parents assisted the clinical team in writing the survey.</p><p>Parents/carers were eligible for inclusion in the study if their child had a diagnosis of SOD, as evidenced by at least two of the following: (a) ONH, (b) hypopituitarism and (c) septum pellucidum/corpus callosum agenesis (partial or complete). The child also had to be aged 0 to 18 years inclusive at the time of data collection (April–August 2024) and have received treatment at Perth Children's Hospital (PCH), Western Australia. Participants were identified through PCH outpatient clinics, MRI records from the Department of Medical Imaging at PCH, and the Western Australian Register of Developmental Anomalies (WARDA) database [<span>4</span>].</p><p>Parent/carers of 35 affected children participated (29 mothers; three fathers; two foster mothers, and one grandparent) of 66 approached. Mean maternal age at birth (available for <i>n</i> = 34) was 27.3 (standard deviation ± 6.5, range: 17.5–45.3) years. The mean child's current age was 10.4 (range 3.1–18.3) years, and 12 were female. Age of diagnosis (available for <i>n</i> = 31) was newborn (<i>n</i> = 14), under 12 months (<i>n</i> = 6), 1–2 years (<i>n</i> = 6), and 3–5 years (<i>n</i> = 5). Eleven had hypopituitarism and 21 had bilateral ONH. Thirteen parents/carers had a tertiary qualification, 20 had completed secondary education, and two had not completed secondary education.</p><p>Figure 1 shows that responses to the six statements varied widely from strongly agree to strongly disagree. Half of participants (49%) agreed that the diagnosis was explained in a comprehensible way by their clinician, that they had opportunities to ask questions, and that they felt well supported by the medical team. Approximately one third agreed that all their concerns were addressed (37%) and that they were given as much information as they needed (31%). Two thirds (69%) reported that they had to find out information for themselves.</p><p>When asked “What written information sources or help groups have you found helpful?” participants nominated VisAbility WA (a local service provider for children and adults with vision impairment), Google, parent online groups, and scholarly literature, but other participants said they couldn't find information or support groups.</p><p>When asked “What aspects of the diagnosis process were well done?” participants referred to the thoroughness of investigations, antenatal detection, the explanation of SOD and support and understanding from staff (nurses, endocrinologist, paediatrician). Other participants recalled diagnosis as a painful experience and mentioned nothing positive: “It's very hard to think of something [that was well done] as it felt very traumatic at the time.”</p><p>When asked “What aspects of the diagnosis process were not well done?” participants mentioned having insufficient information about the condition (“Access to information about the diagnosis &amp; its impacts.”; “I had to do a lot of research myself.”); late diagnosis (“I wasn't told of the diagnosis until 2 weeks post birth [although it was picked up on a brain scan at birth]”; “My child was not diagnosed until after 5 years but continually ended up in hospital in adrenal crisis.”); and a perceived lack of compassion from some staff “At the time I had no idea what was involved and I felt like I wasn't spoken to with compassion. I was only 18 at the time and it was all very overwhelming. We were given very glum outlooks on everything and it felt like my son's life was narrowed down to being very limited.” The initial realisation of the diagnosis was a crucial moment, and most parents preferred to be told as early as possible by a specialist, who would take the time to explain the diagnosis clearly: “The junior doctor on duty wasn't very knowledgeable or empathetic when trying to explain the diagnosis. Once we spoke to [child]'s specialist it was a lot clearer.”</p><p>These experiences are in accord with qualitative interviews of parents of children with ONH from the United States [<span>3</span>], who sought additional information and support soon after diagnosis. One parent from this study reported, “it just felt like we were very much alone, and I didn't realise that there were other families out there.” [<span>3</span>] Several parents of children with ONH commented on the sparsity of information about ONH and others didn't have the “courage” to talk about it or seek information themselves [<span>3</span>].</p><p>Although a small cohort, with less prevalent hypopituitarism (11/35) than is typically reported, the response rate was comparable with other studies and results are similar to another cohort with ONH [<span>3</span>]. A follow-up study comprising either qualitative interviews or focus groups with this population would provide a more detailed picture of the diagnostic experience. These results show that the diagnosis of SOD is a distressing process for parents. Many parents recall feeling traumatised and not sufficiently well-informed. Parents of children with SOD in this study indicated that they wanted (a) a diagnosis and accurate information about their child's condition as early as possible and from a specialist doctor who is knowledgeable about the condition; (b) a contact person whom they can call to ask questions or request assistance; (c) good information sources about SOD for parents and families; and (d) compassion from everyone involved in the diagnostic process. These results have implications for clinical practice and for the development of information resources for the families of children with SOD.</p><p>Ethics approval was obtained from the WA Department of Health and Child and Adolescent Human Research Ethics Committee (RGS6516).</p><p>Informed consent was obtained from parents or legal guardians of children as part of recruitment. When parents deemed their child could understand the requirements and implications of enrolment, children were asked to co-sign.</p><p>The authors declare no conflicts of interest.</p>","PeriodicalId":16648,"journal":{"name":"Journal of paediatrics and child health","volume":"61 8","pages":"1368-1370"},"PeriodicalIF":1.4000,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jpc.70091","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of paediatrics and child health","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jpc.70091","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

Septo-optic dysplasia (SOD) is a congenital disorder affecting 1 in 10,000 births, defined by the presence of at least two of a clinical triad, consisting of optic nerve hypoplasia (ONH), midline brain defects and pituitary hormone deficiency [1]. Children with SOD may have vision impairment, hormonal deficiencies, developmental disorders, or epilepsy, but the clinical picture is highly variable [2]. The complexity of SOD, its interplay with family factors, and the need for multiple specialty commitments can make the diagnosis period a challenging time for families.

Parents of children with ONH (some who had SOD) have reported concerns at diagnosis, such as being given only the name of the condition and needing to seek further information by themselves, and that information being difficult to obtain [3]. These findings mirror concerns raised by families in our clinic population, which led to this study.

The aim of the present study was to investigate parent perceptions of their experiences during their child's SOD diagnosis, with particular focus on the adequacy of information provided.

Data about diagnostic experiences were collected from parents and carers of children with SOD using a survey administered in REDCap, as part of a larger cross-sectional observational study. Parents/carers were asked to indicate their level of agreement to six statements about the diagnostic process and respond to open-ended questions. A consumer reference group of parents assisted the clinical team in writing the survey.

Parents/carers were eligible for inclusion in the study if their child had a diagnosis of SOD, as evidenced by at least two of the following: (a) ONH, (b) hypopituitarism and (c) septum pellucidum/corpus callosum agenesis (partial or complete). The child also had to be aged 0 to 18 years inclusive at the time of data collection (April–August 2024) and have received treatment at Perth Children's Hospital (PCH), Western Australia. Participants were identified through PCH outpatient clinics, MRI records from the Department of Medical Imaging at PCH, and the Western Australian Register of Developmental Anomalies (WARDA) database [4].

Parent/carers of 35 affected children participated (29 mothers; three fathers; two foster mothers, and one grandparent) of 66 approached. Mean maternal age at birth (available for n = 34) was 27.3 (standard deviation ± 6.5, range: 17.5–45.3) years. The mean child's current age was 10.4 (range 3.1–18.3) years, and 12 were female. Age of diagnosis (available for n = 31) was newborn (n = 14), under 12 months (n = 6), 1–2 years (n = 6), and 3–5 years (n = 5). Eleven had hypopituitarism and 21 had bilateral ONH. Thirteen parents/carers had a tertiary qualification, 20 had completed secondary education, and two had not completed secondary education.

Figure 1 shows that responses to the six statements varied widely from strongly agree to strongly disagree. Half of participants (49%) agreed that the diagnosis was explained in a comprehensible way by their clinician, that they had opportunities to ask questions, and that they felt well supported by the medical team. Approximately one third agreed that all their concerns were addressed (37%) and that they were given as much information as they needed (31%). Two thirds (69%) reported that they had to find out information for themselves.

When asked “What written information sources or help groups have you found helpful?” participants nominated VisAbility WA (a local service provider for children and adults with vision impairment), Google, parent online groups, and scholarly literature, but other participants said they couldn't find information or support groups.

When asked “What aspects of the diagnosis process were well done?” participants referred to the thoroughness of investigations, antenatal detection, the explanation of SOD and support and understanding from staff (nurses, endocrinologist, paediatrician). Other participants recalled diagnosis as a painful experience and mentioned nothing positive: “It's very hard to think of something [that was well done] as it felt very traumatic at the time.”

When asked “What aspects of the diagnosis process were not well done?” participants mentioned having insufficient information about the condition (“Access to information about the diagnosis & its impacts.”; “I had to do a lot of research myself.”); late diagnosis (“I wasn't told of the diagnosis until 2 weeks post birth [although it was picked up on a brain scan at birth]”; “My child was not diagnosed until after 5 years but continually ended up in hospital in adrenal crisis.”); and a perceived lack of compassion from some staff “At the time I had no idea what was involved and I felt like I wasn't spoken to with compassion. I was only 18 at the time and it was all very overwhelming. We were given very glum outlooks on everything and it felt like my son's life was narrowed down to being very limited.” The initial realisation of the diagnosis was a crucial moment, and most parents preferred to be told as early as possible by a specialist, who would take the time to explain the diagnosis clearly: “The junior doctor on duty wasn't very knowledgeable or empathetic when trying to explain the diagnosis. Once we spoke to [child]'s specialist it was a lot clearer.”

These experiences are in accord with qualitative interviews of parents of children with ONH from the United States [3], who sought additional information and support soon after diagnosis. One parent from this study reported, “it just felt like we were very much alone, and I didn't realise that there were other families out there.” [3] Several parents of children with ONH commented on the sparsity of information about ONH and others didn't have the “courage” to talk about it or seek information themselves [3].

Although a small cohort, with less prevalent hypopituitarism (11/35) than is typically reported, the response rate was comparable with other studies and results are similar to another cohort with ONH [3]. A follow-up study comprising either qualitative interviews or focus groups with this population would provide a more detailed picture of the diagnostic experience. These results show that the diagnosis of SOD is a distressing process for parents. Many parents recall feeling traumatised and not sufficiently well-informed. Parents of children with SOD in this study indicated that they wanted (a) a diagnosis and accurate information about their child's condition as early as possible and from a specialist doctor who is knowledgeable about the condition; (b) a contact person whom they can call to ask questions or request assistance; (c) good information sources about SOD for parents and families; and (d) compassion from everyone involved in the diagnostic process. These results have implications for clinical practice and for the development of information resources for the families of children with SOD.

Ethics approval was obtained from the WA Department of Health and Child and Adolescent Human Research Ethics Committee (RGS6516).

Informed consent was obtained from parents or legal guardians of children as part of recruitment. When parents deemed their child could understand the requirements and implications of enrolment, children were asked to co-sign.

The authors declare no conflicts of interest.

Abstract Image

孩子被诊断为视隔发育不良的父母经历。
视中隔发育不良(SOD)是一种先天性疾病,发病率为万分之一,由至少两种临床三联征定义,包括视神经发育不全(ONH)、脑中线缺陷和垂体激素缺乏症([1])。患有超氧化物歧化酶的儿童可能有视力障碍、激素缺乏、发育障碍或癫痫,但临床表现差异很大。超氧化物歧化酶的复杂性,它与家庭因素的相互作用,以及需要多个专业承诺,可以使诊断时期的家庭具有挑战性的时间。ONH患儿的父母(一些患有超氧化物歧化酶)报告了诊断时的担忧,例如只被告知病情的名称,需要自己寻找进一步的信息,而这些信息很难获得。这些发现反映了我们门诊人群中家庭提出的担忧,这导致了这项研究。本研究的目的是调查父母在孩子的超氧化物歧化症诊断期间的感受,特别关注所提供信息的充分性。通过REDCap进行的一项调查,从患有SOD的儿童的父母和照顾者那里收集了诊断经历的数据,这是一项更大的横断面观察性研究的一部分。父母/照顾者被要求表明他们对诊断过程的六个陈述的同意程度,并回答开放式问题。由家长组成的消费者参考小组协助临床小组撰写调查问卷。如果父母/照顾者的孩子被诊断为SOD,并且至少有以下两项证明:(a) ONH, (b)垂体功能低下和(c)透明隔/胼胝体发育不全(部分或完全),则父母/照顾者有资格纳入研究。在数据收集时(2024年4月至8月),该儿童必须年龄在0至18岁(含18岁),并在西澳大利亚州珀斯儿童医院(PCH)接受过治疗。通过PCH门诊诊所、PCH医学影像部的MRI记录和西澳大利亚发育异常登记(WARDA)数据库[4]确定参与者。35名受影响儿童的父母/照顾者(29名母亲、3名父亲、2名养母和1名祖父母)参与了66次接触。产妇平均出生年龄(n = 34)为27.3岁(标准差±6.5,范围:17.5-45.3)。目前儿童平均年龄为10.4岁(范围3.1-18.3岁),其中12例为女性。诊断年龄(n = 31)为新生儿(n = 14)、12个月以下(n = 6)、1-2岁(n = 6)和3-5岁(n = 5)。垂体功能减退11例,双侧ONH 21例。13名家长/照顾者拥有高等教育学历,20名完成了中等教育,2名没有完成中等教育。图1显示了对这六种说法的反应从非常同意到非常不同意的差异很大。一半的参与者(49%)同意他们的临床医生以一种可理解的方式解释了诊断,他们有机会提出问题,并且他们感到得到了医疗团队的良好支持。大约三分之一的人认为他们所有的担忧都得到了解决(37%),他们得到了所需的尽可能多的信息(31%)。三分之二(69%)的受访者表示,他们不得不自己查找信息。当被问及“你发现哪些书面信息来源或帮助团体对你有帮助?”时,参与者提名了VisAbility WA(一家为视力障碍儿童和成人提供服务的当地服务提供商)、谷歌、家长在线小组和学术文献,但其他参与者表示他们找不到信息或支持团体。当被问及“诊断过程的哪些方面做得很好?”时,参与者提到了调查的彻彻性、产前检测、SOD的解释以及工作人员(护士、内分泌学家、儿科医生)的支持和理解。其他参与者回忆起诊断是一段痛苦的经历,没有提到任何积极的事情:“很难想到(做得很好)的事情,因为当时感觉非常痛苦。”当被问及“诊断过程的哪些方面做得不好”时,参与者提到对病情的了解不足(“获得诊断及其影响的信息”,“我必须自己做很多研究”);晚期诊断(“我在出生后两周才被告知诊断结果[尽管在出生时通过脑部扫描发现]”;“我的孩子5岁后才被诊断出来,但不断因肾上腺危机而住院。”);“当时我不知道这涉及到什么,我觉得我没有被同情地说话。当时我只有18岁,这一切都让我不知所措。我们对所有事情的看法都非常悲观,感觉我儿子的生活被限制得非常有限。 最初意识到诊断是一个至关重要的时刻,大多数家长更喜欢尽早被专家告知,他们会花时间清楚地解释诊断:“值班的初级医生在试图解释诊断时不是很了解或同情。我们和(儿童)专家谈过之后,情况就清楚多了。”这些经历与来自美国bbb的ONH患儿父母的定性访谈一致,他们在诊断后不久就寻求额外的信息和支持。参与这项研究的一位家长表示:“我们感觉非常孤独,我没有意识到还有其他家庭。”[3]一些患有ONH的孩子的父母评论说关于ONH的信息很少,其他人没有“勇气”谈论它或自己寻找信息[3]。虽然这是一个小的队列,与通常报道的相比,垂体功能减退的发生率较低(11/35),但反应率与其他研究相当,结果与另一个患有ONH bbb的队列相似。对这一人群进行定性访谈或焦点小组的后续研究将提供更详细的诊断经验。这些结果表明,SOD的诊断对家长来说是一个痛苦的过程。许多父母回忆说,他们感到受到了创伤,而且没有得到足够的信息。在这项研究中,患有超氧化物歧化酶儿童的父母表示,他们希望(a)尽早得到诊断,并从了解这种疾病的专科医生那里获得有关孩子病情的准确信息;(b)他们可以致电询问问题或请求协助的联系人;(c)为父母和家庭提供关于超氧化物歧化酶的良好信息来源;(d)参与诊断过程的每个人的同情。这些结果对临床实践和开发超氧化物歧化酶儿童家庭的信息资源具有重要意义。获得了西澳卫生部和儿童与青少年人类研究伦理委员会(RGS6516)的伦理批准。作为招募的一部分,从儿童的父母或法定监护人处获得知情同意。当家长认为他们的孩子能够理解入学的要求和含义时,孩子们被要求共同签名。作者声明无利益冲突。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.90
自引率
5.90%
发文量
487
审稿时长
3-6 weeks
期刊介绍: The Journal of Paediatrics and Child Health publishes original research articles of scientific excellence in paediatrics and child health. Research Articles, Case Reports and Letters to the Editor are published, together with invited Reviews, Annotations, Editorial Comments and manuscripts of educational interest.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信